Advertisement

Endocrine Pathology

, Volume 27, Issue 4, pp 284–311 | Cite as

Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms

  • Stefano La Rosa
  • Fausto Sessa
  • Silvia Uccella
Article

Abstract

The wide application of immunohistochemistry to the study of tumors has led to the recognition that epithelial neoplasms composed of both a neuroendocrine and nonneuroendocrine component are not as rare as traditionally believed. It has been recommended that mixed neuroendocrine-nonneuroendocrine epithelial neoplasms are classified as only those in which either component represents at least 30 % of the lesion but this cutoff has not been universally accepted. Moreover, since their pathogenetic and clinical features are still unclear, mixed neuroendocrine-nonneuroendocrine epithelial neoplasms are not included as a separate clinicopathological entity in most WHO classifications, although they have been observed in virtually all organs. In the WHO classification of digestive tumors, mixed neuroendocrine-nonneuroendocrine neoplasm is considered a specific type and is defined as mixed adenoneuroendocrine carcinoma, a definition that has not been accepted for other organs. In fact, this term does not adequately convey the morphological and biological heterogeneity of digestive mixed neoplasms and has created some misunderstanding among both pathologists and clinicians. In the present study, we have reviewed the literature on mixed neuroendocrine-nonneuroendocrine epithelial neoplasms reported in the pituitary, thyroid, nasal cavity, larynx, lung, digestive system, urinary system, male and female genital organs, and skin to give the reader an overview of the most important clinicopathological features and morphological criteria for diagnosing each entity. We also propose to use the term “mixed neuroendocrine-nonneuroendocrine neoplasm (MiNEN)” to define and to unify the concept of this heterogeneous group of neoplasms, which show different characteristics mainly depending on the type of neuroendocrine and nonneuroendocrine components.

Keywords

Mixed neoplasm Neuroendocrine Mixed adenoneuroendocrine carcinoma Composite tumor Combined tumor Classification 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Solcia E, Klöppel G, Sobin LH (2000) Histological typing of endocrine tumours. WHO international histological classification of tumours, 2nd edition; Springer, BerlinCrossRefGoogle Scholar
  2. 2.
    Hamilton SR, Aaltonen LA (2000) WHO classification of tumours. Pathology & genetics of tumours of the digestive system. IARC Press, LyonGoogle Scholar
  3. 3.
    DeLellis RA, Lloyd RV, Heitz P, Eng C (2004) WHO classification of tumours. Pathology & genetics of tumours of endocrine organs. IARC Press, LyonGoogle Scholar
  4. 4.
    Rindi G, Arnold R, Bosman FT, Capella C, Klimstra DS, Klöppel G, Komminoth P, Solcia E (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system, 4th edn. IARC Press, Lyon, pp 13–14Google Scholar
  5. 5.
    Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) WHO classification of tumours. Pathology & genetics of tumours of the lung, pleura, thymus and heart. IARC Press, LyonGoogle Scholar
  6. 6.
    Volante M, Rindi G, Papotti M (2006) The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. Virchows Arch 449:499–506PubMedCrossRefGoogle Scholar
  7. 7.
    La Rosa S, Marando A, Sessa F, Capella C (2012) Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update. Cancers 4:11–30. doi:  10.3390/cancers4010011 PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Klöppel G (2000) Mixed exocrine-endocrine tumors of the pancreas. Semin Diagn Pathol 17:104–108PubMedGoogle Scholar
  9. 9.
    La Rosa S, Adsay V, Albarello L, Asioli S, Casnedi S, Franzi F, Marando A, Notohara K, Sessa F, Vanoli A, Zhang L, Capella C (2012) Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers. Am J Surg Pathol 36:1782–1795. doi:  10.1097/PAS.0b013e318263209d PubMedCrossRefGoogle Scholar
  10. 10.
    Harada K, Sato Y, Ikeda H, Maylee H, Igarashi S, Okamura A, Masuda S, Nakanuma Y (2012) Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs. Virchows Arch 460:281–289. doi:  10.1007/s00428-012-1212-4 PubMedCrossRefGoogle Scholar
  11. 11.
    Barnes L, Eveson JW, Reichart P, Sidransky D (2005) WHO classification of tumours. Pathology & genetics of head and neck tumours. IARC Press, LyonGoogle Scholar
  12. 12.
    Moch H, Humphrey PA, Ulbright TM, Reuter VE (2016) WHO classification of tumours. Pathology & genetics of tumours of the urinary system and male genital organs, 4th Edition. IARC Press, LyonGoogle Scholar
  13. 13.
    Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera JM, Reuter VE, Robinson BD, Troncoso P, Rubin MA (2014) Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. Am J Surg Pathol 38:756–767. doi:  10.1097/PAS.0000000000000208 PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    La Rosa S, Furlan D, Franzi F, Battaglia P, Frattini M, Zanellato E, Marando A, Sahnane N, Turri-Zanoni M, Castelnuovo P, Capella C (2013) Mixed exocrine-neuroendocrine carcinoma of the nasal cavity: clinico-pathologic and molecular study of a case and review of the literature. Head Neck Pathol 7:76–84. doi:  10.1007/s12105-012-0379-y PubMedCrossRefGoogle Scholar
  15. 15.
    Finzi G, Cerati M, Marando A, Zoia C, Ferreli F, Tomei G, Castelnuovo P, La Rosa S, Capella C (2014) Mixed pituitary adenoma/craniopharyngioma: clinical, morphological, immunohistochemical and ultrastructural study of a case, review of the literature, and pathogenetic and nosological considerations. Pituitary 17:53–59. doi:  10.1007/s11102-013-0465-5 PubMedCrossRefGoogle Scholar
  16. 16.
    LeBoit PE, Burg G, Weedon D, Sarasin A (2006) WHO classification of tumours. Pathology & genetics of skin tumours. IARC Press, LyonGoogle Scholar
  17. 17.
    Asioli S, Foschini MP, Masetti R, Eusebi V (2014) Working formulation of neuroendocrine tumors of the skin and breast. Endocr Pathol 25:141–150. doi:  10.1007/s12022-014-9319-6 PubMedCrossRefGoogle Scholar
  18. 18.
    Vortmeyer AO, Lubensky IA, Merino JA, Wang CY, Pham T, Furth EE, Zhuang Z (1997) Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst 89:1448–1453PubMedCrossRefGoogle Scholar
  19. 19.
    Furlan D, Cerutti R, Genasetti A, Pelosi G, Uccella S, La Rosa S, Capella C (2003) Microallelotyping defines the monoclonal or the polyclonal origin of mixed and collision endocrine-exocrine tumors of the gut. Lab Invest 83:963–971PubMedCrossRefGoogle Scholar
  20. 20.
    Huang J, Behrens C, Wistuba II, Gazdar AF, Jagirdar J (2002) Clonality of combined tumors. Arch Pathol Lab Med 126:437–441PubMedGoogle Scholar
  21. 21.
    Kim KM, Kim MJ, Cho BK, Choi SW, Rhyu MG (2002) Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas. Virchows Arch 440:85–93PubMedCrossRefGoogle Scholar
  22. 22.
    Paniz Mondolfi AE, Slova D, Fan W, Attiyeh FF, Afthinos J, Reidy J, Pang Y, Theise ND (2011) Mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: a possible stem cell tumor? Pathol Int 61:608–614. doi: 10.1111/j.1440-1827.2011.02709.x PubMedCrossRefGoogle Scholar
  23. 23.
    Volante M, Monica V, Birocco N, Brizzi MP, Busso S, Daniele L, La Rosa S, Righi L, Sapino A, Berruti A, Scagliotti GV, Papotti M (2015) Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas. Neuroendocrinology 101:151–160. doi:  10.1159/000375449 PubMedCrossRefGoogle Scholar
  24. 24.
    Scardoni M, Vittoria E, Volante M, Rusev B, Bersani S, Mafficini A, Gottardi M, Giandomenico V, Malleo G, Butturini G, Cingarlini S, Fassan M, Scarpa A (2014) Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components. Neuroendocrinology 100:310–316. doi:  10.1159/000369071 PubMedCrossRefGoogle Scholar
  25. 25.
    Marusyk A, Poliak K (2010) Tumor heterogeneity: causes and consequences. Reviews on Cancer 1805:105–117. doi: 10.1016/j.bbcan.2009.11.002 Google Scholar
  26. 26.
    Uccella S, Sessa F, La Rosa S (2015) Diagnostic approach to neuroendocrine neoplasms of the gastrointestinal tract and pancreas. Turk Patoloji Derg 31(Suppl 1):113–127. doi:  10.5146/tjpath.2015.01319 PubMedGoogle Scholar
  27. 27.
    La Rosa S, Rigoli E, Uccella S, Chiaravalli AM, Capella C (2004) CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors. Virchows Arch 445:248–254PubMedCrossRefGoogle Scholar
  28. 28.
    Erickson LA, Papouchado B, Dimashkieh H, Zhang S, Nakamura N, Lloyd RV (2004) Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. Endocr Pathol 15:247–252PubMedCrossRefGoogle Scholar
  29. 29.
    Hermann G, Konukiewitz B, Schmitt A, Perren A, Klöppel G (2011) Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2. Virchows Arch 459:147–154. doi:  10.1007/s00428-011-1118-6 PubMedCrossRefGoogle Scholar
  30. 30.
    Schmitt AM, Riniker F, Anlauf M, Schmid S, Soltermann A, Moch H, Heitz PU, Klöppel G, Komminoth P, Perren A (2008) Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. Am J Surg Pathol 32:420–425. doi:  10.1097/PAS.0b013e318158a397 PubMedCrossRefGoogle Scholar
  31. 31.
    Koo J, Mertens RB, Mirocha JM, Wang HL, Dhall D (2012) Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin. Mod Pathol 25:893–901. doi:  10.1038/modpathol.2012.34 PubMedCrossRefGoogle Scholar
  32. 32.
    Graham RP, Shrestha B, Caron BL, Smyrk TC, Grogg KL, Lloyd RV, Zhang L (2013) Islet-1 is a sensitive but not entirely specific marker for pancreatic neuroendocrine neoplasms and their metastases. Am J Surg Pathol 37:399–405. doi:  10.1097/PAS.0b013e31826f042c PubMedCrossRefGoogle Scholar
  33. 33.
    Koo J, Zhou X, Moschiano E, De Peralta-Venturina M, Mertens RB, Dhall D (2013) The immunohistochemical expression of Islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin. Endocr Pathol 24:184–190. doi:  10.1007/s12022-013-9264-9 PubMedCrossRefGoogle Scholar
  34. 34.
    Sangoi AR, Ohgami RS, Pai RK, Beck AH, McKenney JK, Pai RK (2011) PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma. Mod Pathol 24:412–424. doi: 10.1038/modpathol.2010.176 PubMedCrossRefGoogle Scholar
  35. 35.
    Long KB, Srivastava A, Hirsch MS, Hornick JL (2010) PAX8 expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors. Am J Surg Pathol 34:723–729. doi:  10.1097/PAS.0b013e3181da0a20 PubMedCrossRefGoogle Scholar
  36. 36.
    Folpe AL, Gown AM, Lamps LW, Garcia R, Dail DH, Zarbo RJ (1999) Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 12:5–8PubMedGoogle Scholar
  37. 37.
    La Rosa S, Chiaravalli AM, Placidi C, Papanikolaou N, Cerati M, Capella C (2010) TTF1 expression in normal lung neuroendocrine cells and related tumors. Immunohistochemical study comparing two different monoclonal antibodies. Virchows Arch 457:497–507. doi:  10.1007/s00428-010-0954-0 PubMedCrossRefGoogle Scholar
  38. 38.
    Agaimy A, Erlenbach-Wünsch K, Konukiewitz B, Schmitt AM, Rieker RJ, Vieth M, Kiesewetter F, Hartmann A, Zamboni G, Perren A, Klöppel G (2013) ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Mod Pathol 26:995–1003. doi:  10.1038/modpathol.2013.40 PubMedCrossRefGoogle Scholar
  39. 39.
    Wheatley T, Clark JD, Stewart S (1986) Craniopharyngioma with hyperprolactinaemia due to a prolactinoma. J Neurol Neurosurg Psychiatry 49:1305–1307PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Asari J, Yamanobe K, Sasaki T, Yamao N, Kodama N (1987) A case of prolactinoma associated with craniopharyngioma. No Shinkei Geka 15:1313–1318PubMedGoogle Scholar
  41. 41.
    Cusimano MD, Kovacs K, Bilbao JM, Tucker WS, Singer W (1988) Suprasellar craniopharyngioma associated with hyperprolactinemia, pituitary lactotroph hyperplasia, and microprolactinoma. J Neurosurg 69:620–623PubMedCrossRefGoogle Scholar
  42. 42.
    Moshkin O, Scheithauer BW, Syro LV, Velasquez A, Horvath E, Kovacs K (2009) Collision tumors of the sella: craniopharyngioma and silent pituitary adenoma subtype 3: case report. Endocr Pathol 20:50–55. doi:  10.1007/s12022-009-9065-3 PubMedCrossRefGoogle Scholar
  43. 43.
    El-Bilbeisi H, Ghannam M, Nimri CF, Ahmad, AT (2010) Craniopharyngioma in a patient with acromegaly due to a pituitary macroadenoma. Ann Saudi Med 30:485–488. doi:  10.4103/0256-4947.70581 PubMedPubMedCentralGoogle Scholar
  44. 44.
    Jin G, Hao S, Xie J, Mi R, Liu F (2013) Collision tumors of the sella: coexistence of pituitary adenoma and craniopharyngioma in the sellar region. World J Surg Oncol 11:178. doi:  10.1186/1477-7819-11-178 PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Prabhakar V, Dayanandam Rao B, Subramanyam MV (1971) Pituitary adenoma associated with craniopharyngioma. J Pathol 103:185–187PubMedCrossRefGoogle Scholar
  46. 46.
    Karavitaki N, Scheithauer BW, Watt J, Ansorge O, Moschopoulos M, Llaguno AV, Wass JAH (2008) Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke’s cleft cyst with corticotroph adenoma. Pituitary 11:317–323. doi:  10.1007/s11102-007-0070-6 PubMedCrossRefGoogle Scholar
  47. 47.
    Yoshida A, Sen C, Asa SL, Rosenblum MK (2008) Composite pituitary adenoma and craniopharyngioma? An unusual sellar neoplasm with divergent differentiation. Am J Surg Pathol 32:1736–1741. doi:  10.1097/PAS.0b013e3181753abd PubMedCrossRefGoogle Scholar
  48. 48.
    Sargis RM, Wollmann RL, Pytel P (2009) A 59 year-old man with sellar lesion. Brain Pathol 19:161–162. doi:  10.1111/j.1750-3639.2008.00240.x PubMedCrossRefGoogle Scholar
  49. 49.
    Gokden M, Mrak RE (2009) Pituitary adenoma with craniopharyngioma component. Hum Pathol 40:1189–1193. doi:  10.1016/j.humpath.2009.02.007 PubMedCrossRefGoogle Scholar
  50. 50.
    Roncaroli F, Martinez-Barbera JP (2016) Craniopharyngioma: pathological and molecular aspects. In: Lania A, Spada A, Lasio G (eds) Diagnosis and management of craniopharyngiomas: key current topics. Springer International,  10.1007/978-3-319-22297-4
  51. 51.
    Wong RL, Kazaure HS, Roman SA, Sosa JA (2012) Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity. Ann Surg Oncol 19:2635–2642. doi:  10.1245/s10434-012-2357-8 PubMedCrossRefGoogle Scholar
  52. 52.
    Papotti M, Negro F, Carney JA, Bussolati G, Lloyd RV (1997) Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases. Virchows Arch 430:397–405PubMedCrossRefGoogle Scholar
  53. 53.
    Sadow PM, Hunt JL (2010) Mixed medullary-follicular-derived carcinomas of the thyroid gland. Adv Anat Pathol 17:282–285. doi:  10.1097/PAP.0b013e3181e4ab3e PubMedCrossRefGoogle Scholar
  54. 54.
    Nangue C, Bron L, Portmann L, Volante M, Ris HB, Monnier P, Andrejevic-Blant S (2009) Mixed medullary-papillary carcinoma of the thyroid: report of a case and review of the literature. Head Neck 31:968–974. doi:  10.1002/hed.20984 PubMedCrossRefGoogle Scholar
  55. 55.
    Saller B, Feldmann G, Haupt K, Broecker M, Janssen OE, Roggendorf M, Mann K, Lu M (2002) RT-PCR-based detection of circulating calcitonin-producing cells in patients with advanced medullary thyroid cancer. J Clin Endocrinol Metab 87:292–296PubMedCrossRefGoogle Scholar
  56. 56.
    Parker LN, Kollin J, Wu SY, Rypins EB, Juler GL (1985) Carcinoma of the thyroid with a mixed medullary, papillary, follicular, and undifferentiated pattern. Arch Intern Med 145:1507–1509PubMedCrossRefGoogle Scholar
  57. 57.
    Papotti M, Volante M, Komminoth P, Sobrinho-Simões M, Bussolati G (2000) Thyroid carcinomas with mixed follicular and C-cell differentiation patterns. Semin Diagn Pathol 17:109–119.PubMedGoogle Scholar
  58. 58.
    Bejarano PA, Nikiforov YE, Swenson ES, Biddinger PW (2000) Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol 8:189–194PubMedGoogle Scholar
  59. 59.
    Jain M, Verma D, Thomas S, Chauhan R (2014) Mixed medullary - papillary carcinoma thyroid: an uncommon variant of thyroid carcinoma. J Lab Physicians 6:133–135. doi:  10.4103/0974-2727.141520 PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Volante M, Papotti M, Roth J, Saremaslani P, Speel EJ, Lloyd RV, Carney JA, Heitz PU, Bussolati G, Komminoth P (1999) Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am J Pathol 155:1499–1509PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Hanna AN1, Michael CW, Jing X (2011) Mixed medullary-follicular carcinoma of the thyroid: diagnostic dilemmas in fine-needle aspiration cytology. Diagn Cytopathol 39:862–865. doi:  10.1002/dc.21560
  62. 62.
    Schmid KO, Aubock L, Albegger K (1979) Endocrine-amphicrine enteric carcinoma of the nasal mucosa. Virchows Arch [A] 383:329–343CrossRefGoogle Scholar
  63. 63.
    Bonato M, Frigerio B, Capella C, Chiaravalli AM, Cerati M (1993) Composite enteric-type adenocarcinoma-carcinoid of the nasal mucosa. Endocr Pathol 4:40–47CrossRefGoogle Scholar
  64. 64.
    Kayakabe M, Takahashi K, Okamiya T, Segawa A, Oyama T, Chikamatsu K (2014) Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: a case report. Oncology Letters 7:1253–1256. doi: 10.3892/ol.2014.1882.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Jain R, Gramigna V, Sanchez-Marull R, Perez-Ordoñez B (2009) Composite intestinal-type adenocarcinoma and small cell carcinoma of sinonasal tract. J Clin Pathol 62:634–637. doi:  10.1136/jcp.2009.065433 PubMedCrossRefGoogle Scholar
  66. 66.
    Barham HP, Said S, Ramakrishnan VR (2013) Colliding tumor of the paranasal sinus. Allergy Rhinol 4:e13-6. doi:  10.2500/ar.2013.4.0040 CrossRefGoogle Scholar
  67. 67.
    Silva EG, Butler JJ, Mackay B, Goepfert H (1982) Neuroblastomas and neuroendocrine carcinomas of the nasal cavity: a proposed new classification. Cancer 50:2388–2405PubMedCrossRefGoogle Scholar
  68. 68.
    Franchi A, Rocchetta D, Palomba A, Degli Innocenti DR, Castiglione F, Spinelli G (2015) Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with immunohistochemical and molecular characterization. Head Neck Pathol 9:107–113. doi:  10.1007/s12105-013-0513-5 PubMedCrossRefGoogle Scholar
  69. 69.
    Huang SF1, Chuang WY, Cheng SD, Hsin LJ, Lee LY, Kao HK (2010) A colliding maxillary sinus cancer of adenosquamous carcinoma and small cell neuroendocrine carcinoma—a case report with EGFR copy number analysis. World J Surg Oncol 8:92. doi:  10.1186/1477-7819-8-92
  70. 70.
    Babin E, Rouleau V, Vedrine PO, Toussaint B, de Raucourt D, Malard O, Cosmidis A, Makaeieff M, Dehesdin D (2006) Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. J Laryngol Otol 120:289–297PubMedCrossRefGoogle Scholar
  71. 71.
    Eusebi V, Betts CM, Giangaspero F (1978) Primary oat cell carcinoma of the larynx. Virchows Arch A Pathol Anat Histol 380: 349–354PubMedCrossRefGoogle Scholar
  72. 72.
    Gnepp DR, Ferlito A, Hyams V (1983) Primary anaplastic small cell (oat cell) carcinoma of the larynx: review of the literature and report of 18 cases. Cancer 51: 1731–1745PubMedCrossRefGoogle Scholar
  73. 73.
    Mills SE, Cooper PH, Garland TA, Johns ME (1983) Small cell undifferentiated carcinoma of the larynx: report of two patients and review of 13 additional cases. Cancer 51: 116–120PubMedCrossRefGoogle Scholar
  74. 74.
    Ferlito A, Recher G, Caruso G (1985) Primary combined small cell carcinoma of the larynx. Am J Otolaryngol 6:302–308PubMedCrossRefGoogle Scholar
  75. 75.
    Chen DA, Mandell-Brown M, Moore SF, Johnson JT (1986) “Composite” tumor: mixed squamous cell and small-cell anaplastic carcinoma of the larynx. Otolaryngol Head Neck Surg 95:99–103PubMedCrossRefGoogle Scholar
  76. 76.
    Cosby WN, Babin RW (1988) Simultaneous oat cell and squamous cell carcinoma of the larynx. Military Med 153:196–198Google Scholar
  77. 77.
    Gianoli GJ, Butcher RB, Martin EJ (1992) Composite tumor of the larynx. Ear Nose Throat J 71:81–82, 85–87Google Scholar
  78. 78.
    Yucel OT, Sokmensuer C, Gedikoglu G, Ayas K (2000) Combined small cell and squamous cell carcinoma of the larynx: short communication. Tumori 86: 434–436PubMedGoogle Scholar
  79. 79.
    Jaiswal VR, Hoang MP (2004) Primary combined squamous and small cell carcinoma of the larynx. A case report and review of the literature. Arch Pathol Lab Med 128:1279–1282PubMedGoogle Scholar
  80. 80.
    Barbeaux A, Duck L, Weynand B, Desuter G, Hamoir M, Gregoire V, Baurain JF, Machiels JP (2006) Primary combined squamous and small cell carcinoma of the larynx: report of two cases and discussion of treatment modalities. Eur Arch Otorhinolaryngol 263:786–790PubMedCrossRefGoogle Scholar
  81. 81.
    Davies-Husband CR, Montgomery P, Premachandra D, Hellquist H (2010) Primary, combined, atypical carcinoid and squamous cell carcinoma of the larynx: a new variety of composite tumour. J Laryngol Otol 124: 226–229. doi:  10.1017/S0022215109991228 PubMedCrossRefGoogle Scholar
  82. 82.
    Aggarwal G, Jackson L, Sharma S (2010) Primary combined small cell carcinoma of larynx with lateralized histologic components and corresponding side specific neck nodal metastasis: report of a unique case and review of literature. Int J Clin Exp Pathol 4: 111–117.PubMedPubMedCentralGoogle Scholar
  83. 83.
    Kołodziej P, Ostasiewicz P, Ziółkowski P (2012) Combined small cell and squamous cell carcinoma of the larynx. Contemp Oncol 16:350–352. doi:  10.5114/wo.2012.30067 Google Scholar
  84. 84.
    Travis WD. Lung tumours with neuroendocrine differentiation (2009) Eur J Cancer 45(Suppl 1):251–266. doi:  10.1016/S0959-8049(09)70040-1 PubMedCrossRefGoogle Scholar
  85. 85.
    Righi L, Volante M, Rapa I, Scagliotti GV, Papotti M (2007) Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data. Virchows Arch 451(Suppl 1):S51-S59PubMedCrossRefGoogle Scholar
  86. 86.
    Ionescu DN, Treaba D, Gilks CB, Leung S, Renouf D, Laskin J, Wood-Baker R, Gown AM (2007) Nonsmall cell lung carcinoma with neuroendocrine differentiation—an entity of no clinical or prognostic significance. Am J Surg Pathol 31:26–32PubMedCrossRefGoogle Scholar
  87. 87.
    Petrović M, Baskić D, Banković D, Ilić N (2011) Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer. Biomarkers 16:311–320. doi:  10.3109/1354750X.2011.560281 PubMedCrossRefGoogle Scholar
  88. 88.
    Nicholson SA, Beasley MB, Brambilla E Hasleton PS, Colby TV, Sheppard MN, Falk R, Travis WD (2002) Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 26:1184–1197PubMedCrossRefGoogle Scholar
  89. 89.
    Ruffini E, Rena O, Oliaro A, Filosso PL, Bongiovanni M, Arslanian A, Papalia E, Maggi G (2002) Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance. Eur J Cardiothorac Surg 22:701–707PubMedCrossRefGoogle Scholar
  90. 90.
    Li DH, Wang C, Chen HJ, Huang H, Ding ZY (2015) Clinical characteristics of the mixed form of neuroendocrine tumor in the lung: a retrospective study in 2501 lung cancer cases. Thorac Cancer 6:25–30. doi:  10.1111/1759-7714.12128 PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Sen F, Borczuk AC (1998) Combined carcinoid tumor of the lung: a combination of carcinoid and adenocarcinoma. Lung Cancer 21:53–58PubMedCrossRefGoogle Scholar
  92. 92.
    Owens CL, Fraire AE (2011) Combined carcinoid tumor and squamous cell carcinoma of lung: expanding the spectrum of combined tumors of lung. Int J Surg Pathol 19:273–275. doi:  10.1177/1066896910397883 PubMedCrossRefGoogle Scholar
  93. 93.
    Okazaki M, Sano Y, Soga Y, Katayama H, Sakao N, Shikatani Y, Yukumi S, Shigematsu H, Sugita A, Izutani H (2015) Combined atypical carcinoid tumour and squamous cell carcinoma of the lung. Intern Med 54:1385–1388. doi:  10.2169/internalmedicine.54.3846 PubMedCrossRefGoogle Scholar
  94. 94.
    Neal MH, Kosinski R, Cohen P, Orenstein JM (1986) Atypical endocrine tumors of the lung: a histologic, ultrastructural, and clinical study of 19 cases. Hum Pathol 17:1264–1277PubMedCrossRefGoogle Scholar
  95. 95.
    Miura K, Morinaga S, Horiuchi M, Shimosato Y, Tsuchiya R (1988) Bronchial carcinoid tumor mimicking acinic cell tumor. Acta Pathol Jpn 38:523–530PubMedGoogle Scholar
  96. 96.
    Rodriguez J, Diment J, Lombardi L, Dominoni F, Tench W, Rosai J (2003) Combined typical carcinoid and acinic cell tumor of the lung: a heretofore unreported occurrence. Hum Pathol 34:1061–1065PubMedCrossRefGoogle Scholar
  97. 97.
    Sano A, Takeuchi E, Hebisawa A, Nakajima Y (2011) Combined typical carcinoid and acinic cell tumor of the lung. Interact Cardiovasc Thorac Surg 12:311–312. doi:  10.1510/icvts.2010.258186 PubMedCrossRefGoogle Scholar
  98. 98.
    Suzuki M, Yazawa T, Ota S, Morimoto J, Yoshino I, Yamanaka S, Inayama Y, Kawabata Y, Shimizu Y, Komatsu M, Notohara K, Koda K, Nakatani Y (2015) High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases. Histopathology 67:806–816. doi:  10.1111/his.12711 PubMedCrossRefGoogle Scholar
  99. 99.
    Wagner PL, Kitabayashi N, Chen YT, Saqi A (2009) Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components. Am J Clin Pathol 131:376–382. doi:  10.1309/AJCPYNPFL56POZQY PubMedCrossRefGoogle Scholar
  100. 100.
    Battafarano RJ, Fernandez FG, Ritter J, Meyers BF, Guthrie TJ, Cooper JD, Patterson GA (2005) Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg 130:166–172. doi: 10.1016/j.jtcvs.2005.02.064 PubMedCrossRefGoogle Scholar
  101. 101.
    Wallace AS, Arya M, Frazier SR, Westgate S, Wang Z, Doll D (2014) Combined small-cell lung carcinoma: an institutional experience. Thorac Cancer 5:57–62. doi:  10.1111/1759-7714.12059.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Lee SY, Shim JJ, Kang KH, Shin BK (2011) Curious case of combined small- and squamous cell carcinoma. J Clin Oncol 29:e186-187. doi:  10.1200/JCO.2010.32.0952 PubMedCrossRefGoogle Scholar
  103. 103.
    Hage R, Elbers JR, Brutel de la Rivière A, van den Bosch JM (1998) Surgery for combined type small cell lung carcinoma. Thorax 53:450–453PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Tatematsu A, Shimizu J, Murakami Y, Horio Y, Nakamura S, Hida T, Mitsudomi T, Yatabe Y (2008) Epidermal growth factor receptor mutations in small cell lung cancer. Clin Cancer Res 14:6092–6096. doi:  10.1158/1078-0432.CCR-08-0332 PubMedCrossRefGoogle Scholar
  105. 105.
    Shiao TH, Chang YL, Yu CJ, Chang YC, Hsu YC, Chang SH, Shih JY, Yang PC (2011) Epidermal growth factor receptor mutations in small cell lung cancer: a brief report. J Thorac Oncol 6:195–198. doi:  10.1097/JTO.0b013e3181f94abb PubMedCrossRefGoogle Scholar
  106. 106.
    Watanabe S, Sone T, Matsui T, Yamamura K, Tani M, Okazaki A, Kurokawa K, Tambo Y, Takato H, Ohkura N, Waseda Y, Katayama N, Kasahara K (2013) Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma. Lung Cancer 82:370–372. doi:  10.1016/j.lungcan.2013.06.003 PubMedCrossRefGoogle Scholar
  107. 107.
    Cordier R (1924) Les cellules argentaffines dans les tumeurs intestinales. Arch Int Med Exp 1:5Google Scholar
  108. 108.
    Reid MD, Akkas G, Basturk O, Adsay V (2015) Mixed adenoneuroendocrine carcinoma of the pancreas. In: La Rosa S, Sessa F (eds) Pancreatic neuroendocrine neoplasms. Practical approach to diagnosis, classification, and therapy. Springer International, pp 155–165Google Scholar
  109. 109.
    La Rosa S, Inzani F, Vanoli A, Klersy C, Dainese L, Rindi G, Capella C, Bordi C, Solcia E (2011) Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Hum. Pathol 42:1373–1384. doi:  10.1016/j.humpath.2011.01.018 PubMedCrossRefGoogle Scholar
  110. 110.
    La Rosa S, Marando A, Furlan D, Sahnane N, Capella C (2012) Colorectal poorly differentiated neuroendocrine carcinomas (NECs) and mixed adenoneuroendocrine carcinomas (MANECs): insights into the diagnostic immunophenotype, assessment of methylation profile and search for prognostic markers. Am J Surg Pathol 36:601–611. doi:  10.1097/PAS.0b013e318242e21c PubMedCrossRefGoogle Scholar
  111. 111.
    Klöppel G, Rindi G, Anlauf M, Perren A, Komminoth P (2007) Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch 451(suppl 1):S9-S27PubMedCrossRefGoogle Scholar
  112. 112.
    Basturk O, Tang L, Hruban RH, Adsay V, Yang Z, Krasinskas AM, Vakiani E, La Rosa S, Jang KT, Frankel WL, Liu X, Zhang L, Giordano TJ, Bellizzi AM, Chen JH, Shi C, Allen P, Reidy DL, Wolfgang CL, Saka B, Rezaee N, Deshpande V, Klimstra DS (2014) Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases. Am J Surg Pathol 38:437–447. doi:  10.1097/PAS.0000000000000169 PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Ohike N, Jürgensen A, Pipeleers-Marichal M, Klöppel G (2003) Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells. Virchows Arch 442:258–265PubMedGoogle Scholar
  114. 114.
    Klimstra DS, Rosai J, Heffess CS (1994) Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol 18:765–778PubMedCrossRefGoogle Scholar
  115. 115.
    Hruban RH, Bishop Pitman M, Klimstra DS (2007). AFIP atlas of tumor pathology series 4. Tumors of the pancreas. America Registry of Pathology, Washington DCGoogle Scholar
  116. 116.
    Yamamoto M, Nakajo S, Miyoshi N, Nakai S, Tahara E (1989) Endocrine cell carcinoma (carcinoid) of the gallbladder. Am J Surg Pathol 13:292–302PubMedCrossRefGoogle Scholar
  117. 117.
    Shintaku M, Kataoka K, Kawabata K (2013) Mixed adenoneuroendocrine carcinoma of the gallbladder with squamous cell carcinomatous and osteosarcomatous differentiation: report of a case. Pathol Int 63:113–119. doi:  10.1111/pin.12029 PubMedCrossRefGoogle Scholar
  118. 118.
    Meguro Y, Fukushima N, Koizumi M, Kasahara N, Hydo M, Morishima K, Sata N, Lefor AT, Yasuda Y (2014) A case of mixed adenoneuroendocrine carcinoma of the gallbladder arising from an intracystic papillary neoplasm associated with pancreatobiliary maljunction. Pathol Int 64: 465–471. doi:  10.1111/pin.12188 PubMedCrossRefGoogle Scholar
  119. 119.
    Garcia MT, Bejarano PA, Yssa M, Buitrago E, Livingstone A (2006) Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature. Virchows Arch 449:376–381PubMedCrossRefGoogle Scholar
  120. 120.
    Barsky SH, Linnoila I, Triche TJ, Costa J (1984) Hepatocellular carcinoma with carcinoid features. Hum Pathol 15:892–894PubMedCrossRefGoogle Scholar
  121. 121.
    Ishida M, Seki K, Tatsuzawa A, Katayama K, Hirose K, Azuma T, Imamura Y, Abraham A, Yamaguchi A (2003) Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case. Surg Today 33:214–218PubMedCrossRefGoogle Scholar
  122. 122.
    Yamaguchi R, Nakashima O, Ogata T, Hanada K, Kumabe T, Kojiro M (2004) Hepatocellular carcinoma with an unusual neuroendocrine component. Pathol Int 54:861–865PubMedCrossRefGoogle Scholar
  123. 123.
    Yang CS, Wen MC, Jan YJ, Wang J, Wu CC (2009) Combined primary neuroendocrine carcinoma and hepatocellular carcinoma of the liver. J Chin Med Assoc 72:430–433. doi:  10.1016/S1726-4901(09)70400-9 PubMedCrossRefGoogle Scholar
  124. 124.
    Kawarabayashi N, Amikura K, Sakamoto H, Yamaura T, Tanaka Y, Oba H, Kurosumi M (2012) Neuroendocrine carcinoma of the liver coexistent with the intrahepatic cholangiocarcinoma. Jpn J Gastroenterol Surg 45:1012–1019CrossRefGoogle Scholar
  125. 125.
    Kano Y, Kakinuma S, Goto F, Azuma S, Nishimura-Sakurai Y, Itsui Y, Nakagawa M, Kudo A, Tanabe M, Kirimura S, Amano T, Ito T, Akashi T, Asahina Y, Watanabe M (2014) Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule. Clin J Gastroenterol 7:449–454. doi: 10.1007/s12328-014-0521-3.PubMedCrossRefGoogle Scholar
  126. 126.
    Tahara E, Ito H, Nakagami K, Shimamoto F, Yamamoto M, Sumii K (1982) Scirrhous argyrophil cell carcinoma of the stomach with multiple production of polypeptide hormones, amine, CEA, lysozyme and HCG. Cancer 49:1904–1915PubMedCrossRefGoogle Scholar
  127. 127.
    Tang LH, Shia J, Soslow RA, Dhall D, Wong WD, O’Reilly E, Qin J, Paty P, Weiser MR, Guillem J, Temple L, Sobin, LH, Klimstra DS (2008) Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol 32:1429–1443. doi:  10.1097/PAS.0b013e31817f1816 PubMedCrossRefGoogle Scholar
  128. 128.
    Marrache F, Cazals-Hatem D, Kianmanesh R, Palazzo L, Couvelard A, O’Toole D, Maire F, Hammel P, Levy P, Sauvanet A, Ruszniewski P (2005) Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association? Pancreas 31:79–83PubMedCrossRefGoogle Scholar
  129. 129.
    Goh BK, Ooi LL, Kumarasinghe MP, Tan YM, Cheow PC, Chow PK, Chung YF, Wong WK (2006) Clinicopathological features of patients with concomitant intraductal papillary mucinous neoplasm of the pancreas and pancreatic endocrine neoplasm. Pancreatology 6:520–526PubMedCrossRefGoogle Scholar
  130. 130.
    Larghi A, Stobinski M, Galasso D, Lecca PG, Costamagna G (2009) Concomitant intraductal papillary mucinous neoplasm and pancreatic endocrine tumour: report of two cases and review of the literature. Dig Liver Dis 41:759–61. doi:  10.1016/j.dld.2009.01.005 PubMedCrossRefGoogle Scholar
  131. 131.
    Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T, Shimamoto F, Hiyama E (2008) Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression. J Surg Oncol 97:469–75PubMedCrossRefGoogle Scholar
  132. 132.
    Ito H, Ito M, Tahara E (1989) Minute carcinoid arising in gastric tubular adenoma. Histopathology 15:96–99PubMedCrossRefGoogle Scholar
  133. 133.
    Harada T, Imura M, Masutani M, Konno S, Miyazaki H, Nomura A, Okushiba S, Katoh H, Itoh T, Shimizu M, Kawakami Y (2001) Carcinoid tumor detected in gastric adenoma during long-term follow-up. Gastrointest Endosc 53:804–806PubMedCrossRefGoogle Scholar
  134. 134.
    De Marco L, Carlinfante G, Botticelli L, Di Maira PV, Putrino I, Cavazza A (2003) Mixed neoplasia of the stomach: description of a case of tubular adenoma combined with carcinoid. Pathologica 95:214–216PubMedGoogle Scholar
  135. 135.
    Coyne JD, O’Connor B (2010) Mixed adenoma-endocrine tumour of the stomach. Histopathology 57:492–494. doi:  10.1111/j.1365-2559.2010.03630.x PubMedCrossRefGoogle Scholar
  136. 136.
    Lee SM, Ahn S, Lee YK, Jang KT, Park CK, Kim KM (2012) Neuroendocrine tumor in gastric adenoma: a diagnostic pitfall mimicking invasive adenocarcinoma. Diagn Pathol 7:102. doi: 10.1186/1746-1596-7-102 PubMedPubMedCentralCrossRefGoogle Scholar
  137. 137.
    Estrella JS, Taggart MW, Rashid A, Abraham SC (2014) Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway. Hum Pathol 45:2051–2058. doi:  10.1016/j.humpath.2014.07.001 PubMedCrossRefGoogle Scholar
  138. 138.
    Varghese NM, Zaitoun AM, Thomas SM, Senapati A, Theodossi A (1994) Composite glandular-carcinoid tumour of the terminal ileum. J Clin Pathol 47:427–429PubMedPubMedCentralCrossRefGoogle Scholar
  139. 139.
    Moyana TN, Qizilbash AH, Murphy F (1988) Composite glandular-carcinoid tumors of the colon and rectum. Report of two cases. Am J Surg Pathol 12:607–611PubMedCrossRefGoogle Scholar
  140. 140.
    Lyda MH, Fenoglio-Preiser CM (1998) Adenoma-carcinoid tumors of the colon. Arch Pathol Lab Med 122:262–265PubMedGoogle Scholar
  141. 141.
    Li Y, Yau A, Schaeffer D, Magliocco A, Gui X, Urbanski S, Waghray R, Owen D, Gao ZH (2011) Colorectal glandular-neuroendocrine mixed tumor: pathologic spectrum and clinical implications. Am J Surg Pathol 35:413–425. doi: 10.1097/PAS.0b013e3182093657 PubMedGoogle Scholar
  142. 142.
    Pulitzer M, Xu R, Suriawinata AA, Waye JD, Harpaz N (2006) Microcarcinoids in large intestinal adenomas. Am J Surg Pathol 30:1531–1536PubMedCrossRefGoogle Scholar
  143. 143.
    Hui CK (2012) Collision adenoma-carcinoid tumour of the colon complicated by carcinoid syndrome. Singapore Med J 53:e195-197PubMedGoogle Scholar
  144. 144.
    Salaria SN, Abu Alfa AK, Alsaigh NY, Montgomery E, Arnold CA (2013) Composite intestinal adenoma-microcarcinoid clues to diagnosing an under-recognised mimic of invasive adenocarcinoma. J Clin Pathol 66:302–306. doi: 10.1136/jclinpath-2012-201314 PubMedCrossRefGoogle Scholar
  145. 145.
    Capella C, Eusebi V, Rosai J (1984) Primary oat cell carcinoma of the kidney. Am J Surg Pathol 8:855–861PubMedCrossRefGoogle Scholar
  146. 146.
    Mills SE, Weiss MA, Swanson PE, Wick MR (1988) Small cell undifferentiated carcinoma of the renal pelvis: a light microscopic, immunocytochemical, and ultrastructural study. Surg Pathol 1:83–88Google Scholar
  147. 147.
    Essenfeld H, Manivel JC, Benedetto P, Albores-Saavedra JA (1990) Small cell carcinoma of the renal pelvis: a clinico-pathogenical, morphological and immunohistochemical study of 2 cases. J Urol 144:344–347PubMedGoogle Scholar
  148. 148.
    Guillou L, Duvoisin B, Chobaz C, Chapuis G, Costa J (1993) Combined small-cell and transitional cell carcinoma of the renal pelvis: a light microscopic, immunohistochemical, and ultrastructural study of a case with literature review. Arch Pathol Lab Med 117:239–243PubMedGoogle Scholar
  149. 149.
    Mazzucchelli L, Studer UE, Kraft R (1995) Small-cell undifferentiated carcinoma of the renal pelvis 26 years after subdiaphragmatic irradiation for non-Hodgkin’s lymphoma. Br J Urol 76:403–404PubMedCrossRefGoogle Scholar
  150. 150.
    Shimasaki N, Inoue K, Nishigawa H, Kuroda N, Shuin T (2005) Combined small cell carcinoma and sarcomatoid squamous cell carcinoma in the renal pelvis. Int J Urol 12:686–689PubMedCrossRefGoogle Scholar
  151. 151.
    Chuang CK, Liao SK (2003) A retrospective immunohistochemical and clinicopathological study of small cell carcinomas of the urinary tract. Chang Gung Med J 26:26–33PubMedGoogle Scholar
  152. 152.
    Kitamura M, Miyanaga T, Hamada M, Nakata Y, Satoh Y, Terakawa T (1997) Small cell carcinoma of the kidney: case report. Int J Urol 4:422–424PubMedCrossRefGoogle Scholar
  153. 153.
    Mackey JR, Au HJ, Hugh J, Venner P (1998) Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol 159:1624–1629PubMedCrossRefGoogle Scholar
  154. 154.
    Palumbo C, Talso M, Dell’Orto PG, Cozzi G, De Lorenzis E, Conti A, Maggioni M, Cesare Rocco BM, Maggioni A, Rocco F (2014) Primary large cell neuroendocrine carcinoma of the renal pelvis: a case report. Urologia 81:57–59. doi:  10.5301/urologia.5000033 PubMedCrossRefGoogle Scholar
  155. 155.
    Remik SC, Ruckdeschel JC (1992) Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy, and outcome. Med Pediatr Oncol 20:89–99CrossRefGoogle Scholar
  156. 156.
    La Rosa S, Bernasconi B, Micello D, Finzi G, Capella C (2009) Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural, and cytogenetic study of a case and review of the literature. Endocr Pathol 20:24–34. doi:  10.1007/s12022-008-9054-y PubMedCrossRefGoogle Scholar
  157. 157.
    Kuroda N, Tamura M, Hes O, Michal M, Gatalica Z (2011) Chromophobe renal cell carcinoma with neuroendocrine differentiation and sarcomatoid change. Pathol Int 61:552–554. doi:  10.1111/j.1440-1827.2011.02689.x PubMedCrossRefGoogle Scholar
  158. 158.
    Parada DD, Peña KB (2008) Chromophobe renal cell carcinoma with neuroendocrine differentiation. APMIS 116:859–865PubMedCrossRefGoogle Scholar
  159. 159.
    Peckova K, Martinek P, Ohe C, Kuroda N, Bulimbasic S, Condom Mundo E, Perez Montiel D, Lopez JI, Daum O, Rotterova P, Kokoskova B, Dubova M, Pivovarcikova K, Bauleth K, Grossmann P, Hora M, Kalusova K, Davidson W, Slouka D, Miroslav S, Buzrla P, Hynek M, Michal M, Hes O (2015) Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature. Ann Diagn Pathol 19:261–268. doi:  10.1016/j.anndiagpath.2015.05.001 PubMedCrossRefGoogle Scholar
  160. 160.
    Ohe C, Kuroda N, Matsuura K, Kai T, Moriyama M, Sugiguchi S, Terahata S, Hosaka N, Hes O, Michal M, Matsuda T, Uemura Y (2014) Chromophobe renal cell carcinoma with neuroendocrine differentiation/morphology: a clinicopathological and genetic study of three cases. Human Pathology: Case Reports 1: 31–39. doi: http://dx.doi.org/ 10.1016/j.ehpc.2014.08.003
  161. 161.
    Mokhtar GA, Al-Zahrani R (2015) Chromophobe renal cell carcinoma of the kidney with neuroendocrine differentiation: a case report with review of literature. Urol Ann 7:383–386. doi:  10.4103/0974-7796.158506 PubMedPubMedCentralGoogle Scholar
  162. 162.
    Deshmukh MK, Epari S, Menon S, Desai SB, Tongaukar H (2011) Composite epithelial kidney tumor comprising of adeno and neuroendocrine carcinomatous components: an unusual variant of renal cell carcinoma. Indian J Pathol Microbiol 54:809–813. doi:  10.4103/0377-4929.91528 PubMedGoogle Scholar
  163. 163.
    Bressenot A, Delaunay C, Gauchotte G, Oliver A, Boudrant G, Montagne K (2010) Composite renal cell carcinoma with clear cell renal cell carcinomatous and carcinoid tumoral elements: a first case report. J Clin Pathol 63:174–176. doi:  10.1136/jcp.2009.070292 PubMedCrossRefGoogle Scholar
  164. 164.
    Al-Ahmadie H, Compérat E, Epstein JI (2016) Neuroendocrine tumors. In Moch H, Humphrey PA, Ulbright TM, Reuter VE (2016) WHO classification of tumours. Pathology & genetics of tumours of the urinary system and male genital organs, 4th Edition. IARC Press, Lyon, pp 117–119Google Scholar
  165. 165.
    Wang X, MacLennan GT, Lopez-Beltran A, Cheng L (2007) Small cell carcinoma of the urinary bladder-histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis. Appl Immunohistochem Mol Morphol 15:8–18PubMedCrossRefGoogle Scholar
  166. 166.
    Zhao X, Flynn EA (2012) Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy. Arch Pathol Lab Med 136:1451–1459. doi:  10.5858/arpa.2011-0267-RS PubMedCrossRefGoogle Scholar
  167. 167.
    Cramer SF, Aikawa M, Cebelin M (1981) Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer 47:724–730.PubMedCrossRefGoogle Scholar
  168. 168.
    Shanks JH, Iczkowski KA (2009) Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Histopathology 54:885–900.doi:  10.1111/j.1365-2559.2008.03167.x PubMedCrossRefGoogle Scholar
  169. 169.
    Vakar-Lopez F, True LD (2007) How wide is the spectrum of neuroendocrine carcinoma of the urinary bladder? Am J Clin Pathol 128:723–725. doi:  10.1309/N5N5Y8VD90W91WQP PubMedCrossRefGoogle Scholar
  170. 170.
    Buza N, Cohen PJ, Hui P, Parkash V (2010) Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder. Int J Surg Pathol 18:94–102. doi: 10.1177/1066896909359914 PubMedCrossRefGoogle Scholar
  171. 171.
    La Rosa S, Marando A, Gatti G, Rapa I, Volante M, Papotti M, Sessa F, Capella C (2013) Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases. Hum Pathol 44:1391–1399. doi: http://dx.doi.org/ 10.1016/j.humpath.2012.11.013
  172. 172.
    Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, Lopez-Beltran A, Yang XJ, Koch MO, Zhang S, Pan CX, Baldridge LA (2005) Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol 166:1533–1539PubMedPubMedCentralCrossRefGoogle Scholar
  173. 173.
    Abbosh PH, Wang M, Eble JN, Lopez-Beltran A, Maclennan GT, Montironi R, Zheng S, Pan CX, Zhou H, Cheng L (2008) Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. Mod Pathol 21:355–362PubMedCrossRefGoogle Scholar
  174. 174.
    Epstein JI, Amin MB, Evans AJ, Huang J, Rubin MA (2016) Neuroendocrine tumors. In Moch H, Humphrey PA, Ulbright TM, Reuter VE (2016) WHO classification of tumours. Pathology & genetics of tumours of the urinary system and male genital organs, 4th Edition. IARC Press, Lyon, pp 172–174Google Scholar
  175. 175.
    Weinstein MH, Partin AW, Veltri RW, Epstein JI (1996) Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy. Hum Pathol 27:683–687PubMedCrossRefGoogle Scholar
  176. 176.
    Bollito E, Berruti A, Bellina M, Mosca A, Leonardo E, Tarabuzzi R, Cappia S, Ari MM, Tampellini M, Fontana D, Gubetta L, Angeli A, Dogliotti L (2001) Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. Ann Oncol 12(Suppl 2):S159-S164PubMedCrossRefGoogle Scholar
  177. 177.
    Segawa N, Mori I, Utsunomiya H, Nakamura M, Nakamura Y, Shan L, Kakudo K, Katsuoka Y (2001) Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer. Pathol Int 51:452–459PubMedCrossRefGoogle Scholar
  178. 178.
    Cheville JC, Tindall D, Boelter C, Jenkins R, Lohse CM, Pankratz VS, Sebo TJ, Davis B, Blute ML (2002) Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival. Cancer 95:1028–1036PubMedCrossRefGoogle Scholar
  179. 179.
    Tarle M, Ahel MZ, Kovacić K (2002) Acquired neuroendocrine-positivity during maximal androgen blockade in prostate cancer patients. Anticancer Res 22:2525–2529PubMedGoogle Scholar
  180. 180.
    Wang W, Epstein JI (2008) Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol 32:65–71PubMedCrossRefGoogle Scholar
  181. 181.
    Deorah S, Rao MB, Raman R, Gaitonde K, Donovan JF (2012) Survival of patients with small cell carcinoma of the prostate during 1973–2003: a population-based study. BJU Int 109:824–30. doi:  10.1111/j.1464-410X.2011.10523.x PubMedCrossRefGoogle Scholar
  182. 182.
    Yuan TC, Veeramani S, Lin MF (2007) Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr Relat Cancer 14:531–547PubMedCrossRefGoogle Scholar
  183. 183.
    Wang HT, Yao YH, Li BG, Tang Y, Ji, Chang W, Zhang J (2014) Neuroendocrine prostate cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis—a systematic review and pooled analysis. J Clin Oncol 32:3383–3390 doi:  10.1200/JCO.2014.57.5100 PubMedCrossRefGoogle Scholar
  184. 184.
    Ismail AHR, Landry F, Aprikian AG, Chevalier S (2002) Androgen ablation promotes neuroendocrine cell differentiation in dog and human prostate. Prostate 51:117–125CrossRefGoogle Scholar
  185. 185.
    Ito T, Yamamoto S, Ohno Y, Namiki K, Aizawa T, Akiyama A, Tachibana M (2001) Upregulation of neuroendocrine differentiation in prostate cancer after androgen deprivation therapy, degree and androgen independence. Oncol Rep 8:1221–1224PubMedGoogle Scholar
  186. 186.
    Shen R, Dorai T, Szaboles M, Katz AE, Olsson CA, Buttyan R (1997) Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone depleted medium. Urol Oncol 3:67–75PubMedCrossRefGoogle Scholar
  187. 187.
    Chun YK (2015) Neuroendocrine tumors of the female reproductive tract: a literature review. J Pathol Transl Med 49:450–461. doi:  10.4132/jptm.2015.09.20 PubMedCentralCrossRefGoogle Scholar
  188. 188.
    Kurman RJ, Carcangiu ML, Herrington CS, Young RH (2014). WHO classification of tumours of the female reproductive organs. WHO classification of tumours. IARC Press, LyonGoogle Scholar
  189. 189.
    Taube ET, Denkert C, Pietzner K, Dietel M, Sehouli J, Darb-Esfahani S (2015) Prognostic impact of neuroendocrine differentiation in high-grade serous ovarian carcinoma. Virchows Arch 466:333–342. doi:  10.1007/s00428-014-1710-7 PubMedCrossRefGoogle Scholar
  190. 190.
    Ishida GM, Kato N, Hayasaka T, Saito M, Kobayashi H, Katayama Y, Sasou S, Yaegashi N, Kurachi H, Motoyama T (2004) Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study. Int J Gynecol Pathol 23:366–372PubMedCrossRefGoogle Scholar
  191. 191.
    Horn LC, Hentschel B, Bilek K, Richter CE, Einenkel J, Leo C (2006) Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index. Ann Diagn Pathol 10:140–143PubMedCrossRefGoogle Scholar
  192. 192.
    Li JD, Zhuang Y, Li YF, Feng YL, Hou JH, Chen L, Zhu AN, Wu QL, Yun JP (2011) A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-centre study of 25 cases. J Clin Pathol 64:1102–1107. doi:  10.1136/jclinpath-2011-200274 PubMedCrossRefGoogle Scholar
  193. 193.
    Rekhi B, Patil B, Deodhar KK, Maheshwari A, A Kerkar R, Gupta S, Tongaonkar HB, Shrivastava SK (2013) Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India. Ann Diagn Pathol 17:1–9. doi:  10.1016/j.anndiagpath.2012.01.009
  194. 194.
    Munakata S1, Iwai E, Tanaka T, Nakamura M, Kanda T (2013) Malignant müllerian mixed tumor of the uterine cervix with a small cell neuroendocrine carcinoma component. Case Rep Pathol 2013:630859. doi:  10.1155/2013/630859
  195. 195.
    Abeler VM, Holm R, Nesland JM, Kjfrstad KE (1994) Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer 73:672–677PubMedCrossRefGoogle Scholar
  196. 196.
    Stoler MH, Mills SE, Gersell DJ, Walker AN (1991) Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol 15:28–32PubMedCrossRefGoogle Scholar
  197. 197.
    Albores-Saavedra J, Ashfaq R, Henson DE (1996) Carcinoid and small cell carcinomas of the uterine cervix. Lab Invest 74:87–91Google Scholar
  198. 198.
    Conner MG, Richter H, Moran C, Hameed A, Albores-Saaverdra J (2002) Small cell carcinoma of the cervix: a clinicopathologic and immunohistochemical study of 23 cases. Ann Diagn Pathol 6:345–348PubMedCrossRefGoogle Scholar
  199. 199.
    Chavez-Blanco A, Taja-Chayeb L, Cetina L, Chona-Vilchis G, Trjo-Becerril C, Perez-Cardenas E, Segura-Pacheco B, Acuña-González C, Dueñas-Gonzalez A (2002) Neuroendocrine marker expression in cervical mixed carcinomas of non-small cell type. Int J Gynecol Pathol 21:368–374PubMedCrossRefGoogle Scholar
  200. 200.
    Mannion C, Park WS, Man YG, Zhuang Z, Albores-Saavedra J, Tavassoli FA (1998) Endocrine tumors of the cervix: morphologic assessment, expression of human papillomavirus, and evaluation for loss of heterozygosity on 1p, 3p, 11q, and 17p. Cancer 83:1391–400PubMedCrossRefGoogle Scholar
  201. 201.
    Matsumoto H, Nasu K, Kai K, Nishida M, Narahara H, Nishida H (2016) Combined large-cell neuroendocrine carcinoma and endometrioid adenocarcinoma of the endometrium: a case report and survey of related literature. J Obstet Gynaecol Res 42:206–10. doi:  10.1111/jog.12881 PubMedCrossRefGoogle Scholar
  202. 202.
    van Hoeven KH, Hudock JA, Woodruff JM, Suhrland MJ (1995) Small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol 4:21–29CrossRefGoogle Scholar
  203. 203.
    Tamura T1, Jobo T, Watanabe J, Kanai T, Kuramoto H (2006) Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium. Int J Gynecol Cancer 16:821–826Google Scholar
  204. 204.
    George E, Manivel JC, Dehner LP, Wick MR (1991) Malignant mixed müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation. Hum Pathol 22:215–223PubMedCrossRefGoogle Scholar
  205. 205.
    Grandjean M, Legrand L, Waterkeyn M, Baurain JF, Jadoul P, Donnez J, Marbaix E (2007) Small cell carcinoma of pulmonary type inside a microinvasive mucinous cystadenocarcinoma of the ovary: a case report. Int J Gynecol Pathol 26:426–31.PubMedCrossRefGoogle Scholar
  206. 206.
    Rubio A, Schuldt M, Chamorro C, Crespo-Lora V, Nogales FF (2015) Ovarian small cell carcinoma of pulmonary type arising in mature cystic teratomas with metastases to the contralateral ovary. Int J Surg Pathol 23:388–392. doi:  10.1177/1066896915586254 PubMedCrossRefGoogle Scholar
  207. 207.
    Choi YD, Lee JS, Choi C, Park CS, Nam JH (2007) Ovarian neuroendocrine carcinoma, non-small cell type, associated with serous carcinoma. Gynecol Oncol 104:747–752PubMedCrossRefGoogle Scholar
  208. 208.
    Eichhorn JH, Lawrence WD, Young RH, Scully RE (1996) Ovarian neuroendocrine carcinomas of non-small-cell type associated with surface epithelial adenocarcinomas: a study of five cases and review of the literature. Int J Gynecol Pathol 15:303–314PubMedCrossRefGoogle Scholar
  209. 209.
    Yasuoka H, Tsujimoto M, Fujita S, Kunishige I, Nishio Y, Kodama R, Oishi H, Sanke T, Nakamura Y (2009) Monoclonality of composite large cell neuroendocrine carcinoma and mucinous epithelial tumor of the ovary: a case study. Int J Gynecol Pathol; 28:55–58. doi:  10.1097/PGP.0b013e31817fb419 PubMedCrossRefGoogle Scholar
  210. 210.
    Baker PM1, Oliva E, Young RH, Talerman A, Scully RE (2001) Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases. Am J Surg Pathol 25:557–568Google Scholar
  211. 211.
    Schulz T, Hartschuh W (1997) Merkel cells are absent in basal cell carcinomas but frequently found in trichoblastomas. An immunohistochemical study. J Cutan Pathol 24:14–24Google Scholar
  212. 212.
    Collina G, Eusebi V, Capella C, Rosai J (1998) Merkel cell differentiation in trichoblastoma. Virchows Arch 433:291–296PubMedCrossRefGoogle Scholar
  213. 213.
    Busam KJ, Jungbluth AA, Rekthman N, Coit D, Pulitzer M, Bini J, Arora R, Hanson NC, Tassello JA, Frosina D, Moore P, Chang Y (2009) Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol 33:1378–1385. doi:  10.1097/PAS.0b013e3181aa30a5 PubMedPubMedCentralCrossRefGoogle Scholar
  214. 214.
    Pulitzer MP, Brannon AR, Berger MF, Louis P, Scott SN, Jungbluth AA, Coit DG, Brownell I, Busam KJ (2015) Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma. Mod Pathol 28:1023–1032. doi:  10.1038/modpathol.2015.60 PubMedPubMedCentralCrossRefGoogle Scholar
  215. 215.
    Lai JH, Fleming KE, Ly TY, Pasternak S, Godlewski M, Doucette S, Walsh NM (2015) Pure versus combined Merkel cell carcinomas: immunohistochemical evaluation of cellular proteins (p53, Bcl-2, and c-kit) reveals significant overexpression of p53 in combined tumors. Hum Pathol 46:1290–1296. doi:  10.1016/j.humpath.2015.05.008 PubMedCrossRefGoogle Scholar
  216. 216.
    Suárez AL, Louis P, Kitts J, Busam K, Myskowski PL, Wong RJ, Chen CS, Spencer P, Lacouture M, Pulitzer MP (2015) Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC). J Am Acad Dermatol 73:968–975. doi:  10.1016/j.jaad.2015.08.041 PubMedCrossRefGoogle Scholar
  217. 217.
    Narisawa Y, Koba S, Inoue T, Nagase K (2015) Histogenesis of pure and combined Merkel cell carcinomas: an immunohistochemical study of 14 cases. J Dermatol 42:445–452. doi:  10.1111/1346-8138.12808 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of PathologyOspedale di CircoloVareseItaly
  2. 2.Department of Surgical and Morphological SciencesUniversity of InsubriaVareseItaly

Personalised recommendations